Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

50.09
Delayed Data
As of 3:59pm ET
 +0.89 / +1.81%
Today’s Change
26.80
Today|||52-Week Range
73.54
+11.00%
Year-to-Date
This Value Screen Is Our Top Performer This Year
2:33pm / Zacks.com - Paid Partner Content
Acorda Shelves Development of Epilepsy Treatment, Plumiaz
May 23 / Zacks.com - Paid Partner Content
Xenoport to be Acquired by Arbor Pharmaceuticals; Stock Up
12:13pm / Zacks.com - Paid Partner Content
Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 8.7%
May 23 / Zacks.com - Paid Partner Content
Pfizer Champix's Label to Include More Data, Warning Lifted
10:02am / Zacks.com - Paid Partner Content
Horizon (HZNP) to Buy Global Rights to Actimmune, Stock Down
May 20 / Zacks.com - Paid Partner Content
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
9:01am / Zacks.com - Paid Partner Content
Pronai Therapeutics (DNAI) Shows Strength: Stock Rises 7.4%
May 20 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Trumenba Accepted for Review in the EU
May 23 / Zacks.com - Paid Partner Content
Agios Strikes Metabolic Immuno-Oncology Deal with Celgene
May 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close49.20
Today’s open49.69
Day’s range48.70 - 50.52
Volume177,050
Average volume (3 months)226,064
Market cap$565.5M
Dividend yield--
Data as of 3:59pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+34.80%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+36.36%
P/E ratio47.1
Price/Sales6.83
Price/Book3.54

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc+0.63+9.53%
FMIFoundation Medicine ...+1.24+7.11%
RTRXRetrophin Inc+0.41+2.44%
ATRAAtara Biotherapeutic...+0.43+2.45%
Data as of 3:59pm ET, 05/24/2016

Financials

Next reporting dateAugust 1, 2016
EPS forecast (this quarter)$0.80
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts

Partner Offers

Search for Jobs